文献速递产科麻醉区域麻醉与超声

椎管内分娩镇痛与产妇发热:叙述性综述

Neuraxial labour analgesia and maternal fever: A narrative review.
PubMed 文献 · Eur J Anaesthesiol · 2025-09-24

本文为叙述性综述,探讨椎管内分娩镇痛与产妇发热(即硬膜外相关产妇发热,ERMF)的关联。综述梳理了ERMF的两大病理生理假说(无菌性炎症假说与体温调节改变假说),分析了患者特征、妊娠与分娩因素、助产及产科干预和硬膜外相关因素对ERMF风险的影响,并讨论了现有产妇发热情况下椎管内镇痛的管理。作者指出目前尚无明确证据支持任何预防ERMF的干预措施,呼吁未来研究将ERMF作为产时发热的独立类别加以区分。

要点

  • ERMF的主要假说为无菌性炎症与体温调节改变,确切机制尚待阐明。
  • 多种患者、妊娠、分娩及硬膜外因素可增加ERMF风险,但无证据支持特定预防干预。
  • 未来研究应将ERMF作为产时发热的独立类别加以区分。

核心结论

  • 椎管内分娩镇痛与产妇发热存在关联,但其病理生理、临床意义、预防策略和治疗方式仍需进一步研究。

研究设计与样本

  • 叙述性综述,探讨椎管内分娩镇痛与产妇发热的关联、病理生理机制、潜在影响及现有发热时的管理。

主要发现

  • 解释ERMF的两大主要理论为无菌性炎症假说和体温调节改变假说。
  • 患者特征、妊娠与分娩特征、助产和/或产科干预以及硬膜外相关因素均可增加ERMF风险。
  • 目前无明确证据支持推荐任何干预措施来预防ERMF的发生。
  • 产妇发热对产妇、胎儿和新生儿的不良影响已被强调,但以ERMF为研究焦点时许多不良结局尚未被确切证实。

临床怎么用

  • 临床应关注椎管内分娩镇痛期间产妇发热的发生,并识别相关危险因素。
  • 在现有产妇发热情况下,需考虑椎管内镇痛的管理策略。
  • 目前不推荐任何特定干预用于预防ERMF,需个体化评估。

局限性

  • 本文为叙述性综述,未提供系统检索策略或定量合并分析。
  • 许多ERMF相关不良结局尚未在以ERMF为焦点的研究中被确切证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neuraxial labour analgesia is considered the 'gold-standard' technique for the provision of analgesia during vaginal birth. Recently, there has been growing interest in the potential impacts of labour epidural analgesia beyond pain relief. One particular concern is its association with the development of maternal fever, so-called epidural-related maternal fever (ERMF). Hyperthermia during labour is a significant clinical concern, as it can impact both maternal and neonatal outcomes. This narrative review explores the association between epidural analgesia and maternal fever, outlines its suggested pathophysiological mechanisms, examines its potential implications and considers the management of neuraxial analgesia in the context of existing maternal fever. The two main theories explaining the development of ERMF are the sterile inflammation hypothesis, and the altered thermoregulation hypothesis. Patient characteristics, features of pregnancy and labour, midwifery and/or obstetric interventions and epidural-related factors can all contribute to an increased risk of developing ERMF. Although these factors may be manipulated to reduce ERMF incidence, there is no clear evidence that supports the recommendation of any intervention to prevent ERMF development. The associated detrimental effects of maternal fever on the woman, foetus, and newborn are highlighted, although many of these adverse outcomes have not been definitively established when ERMF has been the focus of study. There remains a significant need to further understand the pathophysiology, clinical significance, preventive strategies and treatment modalities of ERMF. It is crucial that future studies distinguish ERMF as a distinct category within maternal intrapartum fever.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Attard Cortis P, Bleeser T, Devroe S, et al. Neuraxial labour analgesia and maternal fever: A narrative review. Eur J Anaesthesiol. 2025. PMID: 41017360. doi:10.1097/EJA.0000000000002280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。